146 related articles for article (PubMed ID: 11004676)
1. Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines.
Maier S; Reich E; Martin R; Bachem M; Altug V; Hautmann RE; Gschwend JE
Int J Cancer; 2000 Oct; 88(2):245-51. PubMed ID: 11004676
[TBL] [Abstract][Full Text] [Related]
2. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
Gleave ME; Sato N; Sadar M; Yago V; Bruchovsky N; Sullivan L
J Cell Biochem; 1998 Jun; 69(3):271-81. PubMed ID: 9581866
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
Gupta S; Ahmad N; Nieminen AL; Mukhtar H
Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
[TBL] [Abstract][Full Text] [Related]
4. Tributyrin, a butyrate precursor, impairs growth and induces apoptosis and differentiation in pancreatic cancer cells.
Gaschott T; Maassen CU; Stein J
Anticancer Res; 2001; 21(4A):2815-9. PubMed ID: 11724360
[TBL] [Abstract][Full Text] [Related]
5. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of zinc on human prostatic carcinoma cell growth.
Liang JY; Liu YY; Zou J; Franklin RB; Costello LC; Feng P
Prostate; 1999 Aug; 40(3):200-7. PubMed ID: 10398282
[TBL] [Abstract][Full Text] [Related]
7. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer.
Kuefer R; Hofer MD; Altug V; Zorn C; Genze F; Kunzi-Rapp K; Hautmann RE; Gschwend JE
Br J Cancer; 2004 Jan; 90(2):535-41. PubMed ID: 14735205
[TBL] [Abstract][Full Text] [Related]
9. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
Kim J; Park H; Im JY; Choi WS; Kim HS
Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
[TBL] [Abstract][Full Text] [Related]
11. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
[TBL] [Abstract][Full Text] [Related]
12. Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells.
Chen KC; Peng CC; Peng RY; Su CH; Chiang HS; Yan JH; Hsieh-Li HM
Nutr Cancer; 2007; 57(1):111-21. PubMed ID: 17516868
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
[TBL] [Abstract][Full Text] [Related]
14. Selenium effects on prostate cell growth.
Menter DG; Sabichi AL; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
18. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
19. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
Miyake H; Pollak M; Gleave ME
Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
Lu S; Tsai SY; Tsai MJ
Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
